lymphoma treatment | Surveillance after treatment for lymphoma

Surveillance after treatment for lymphoma



Whether it is Lymphoma Hodgkin, an aggressive non-Hodgkin Lymphoma or indolent Lymphoma, monitoring may include terms tailored to each situation, but common points to compose personalized program the after lymphoma.
Know the probabilities of success of the treatment and the sustainable maintenance of response.
Early diagnose possible relapses to provide adequate treatment.
Detect possible complications and limit their effects for the patient.
Inform the patient of possible risk factors and to implement measures to reduce them.
Clinical monitoring is essential and a priority on further tests. It is based on the symptoms and findings of the patient himself, his decision to consult and talk to his doctor in the event of anomaly or interrogation. Medical clinical examination is necessary, and is supplemented by para-cliniques reviews, depending on the type of lymphoma, treatment and the time since the end of the treatment. Common tests include a complete blood count and some lymphomas a dosage of the LDH; Unlike other cancers, there is no tumor marker used for surveillance. Medical Imaging tests may include scanner, x-ray of thorax, ultrasound of the abdomen and the pelvis.
Surveillance must be shared between the patient, the doctor, the doctor onco-hematologist and, depending on the needs, other medical specialists.
When the patient is in a clinical trial, follow-up visits are carried out in the Center where the treatment has been achieved, according to a timetable defined at the start of the treatment. In general, monitoring is adapted according to the type of lymphoma, the treatment results, events related to lymphoma and needs of the patient. The terms are defined by the referring team and doctor. Consultations are carried out several times per year during the first 2-5 years after initial treatment, then once per year up to 10 years, then more spaced way, throughout the life.